Sheng et al. reported a case presenting a 76-year-old female with pSS and relapsed DLBCL treated with CD19-directed CAR-T cells (axi-cabtagene ciloleucel) following fludarabine/CYC LDC and bridging radiotherapy [44]. Here, CD19 is linked to diffuse large B-cell lymphoma.